BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15710921)

  • 41. Pseudomembranous colitis.
    Keighley MR
    Schweiz Rundsch Med Prax; 1982 Jan; 71(3):98-106. PubMed ID: 7038661
    [No Abstract]   [Full Text] [Related]  

  • 42. [Infections with Clostridium difficile following antibiotic therapy].
    Scheppach W
    MMW Fortschr Med; 2009 Oct; 151(40):47-9. PubMed ID: 19927920
    [No Abstract]   [Full Text] [Related]  

  • 43. Metronidazole or vancomycin for Clostridium difficile associated diarrhoea.
    Gordon RS
    Lancet; 1983 Dec; 2(8364):1417. PubMed ID: 6140511
    [No Abstract]   [Full Text] [Related]  

  • 44. Inflammatory Bowel Disease and Clostridium difficile-associated diarrhea: a growing problem.
    Tremaine WJ
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):310-1. PubMed ID: 17368229
    [No Abstract]   [Full Text] [Related]  

  • 45. Editorial Commentary: the trials and tribulations of treating Clostridium difficile infection-one step backward, one step forward, but still progress.
    Wilcox MH
    Clin Infect Dis; 2014 Aug; 59(3):355-7. PubMed ID: 24799325
    [No Abstract]   [Full Text] [Related]  

  • 46. Recurrent Clostridium difficile colitis.
    Joyce AM; Burns DL
    Compr Ther; 2004; 30(3):160-3. PubMed ID: 15793316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection.
    Louie TJ; Emery J; Krulicki W; Byrne B; Mah M
    Antimicrob Agents Chemother; 2009 Jan; 53(1):261-3. PubMed ID: 18955523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comment on: Increasing incidence of community-associated atypical Clostridium difficile disease in children.
    Pant C; Bass PF
    Clin Pediatr (Phila); 2010 Sep; 49(9):907; author reply 908. PubMed ID: 20693524
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of recurrent Clostridium difficile infection: a systematic review.
    O'Horo JC; Jindai K; Kunzer B; Safdar N
    Infection; 2014 Feb; 42(1):43-59. PubMed ID: 23839210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Limited clinical utility of Clostridium difficile toxin testing in infants in a pediatric hospital.
    Tang P; Roscoe M; Richardson SE
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):91-4. PubMed ID: 15964495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clostridium difficile infection: new insights into management.
    Khanna S; Pardi DS
    Mayo Clin Proc; 2012 Nov; 87(11):1106-17. PubMed ID: 23127735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The approach to recurrent infections with Clostridium difficile].
    Paz Z; Altman A
    Harefuah; 2008 Nov; 147(11):864-5, 942. PubMed ID: 19264004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of OPT-80 against Clostridium difficile.
    Ackermann G; Löffler B; Adler D; Rodloff AC
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2280-2. PubMed ID: 15155234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis.
    Ariano RE; Zhanel GG; Harding GK
    CMAJ; 1990 May; 142(10):1049-51. PubMed ID: 2186849
    [No Abstract]   [Full Text] [Related]  

  • 55. Alternative treatments for Clostridium difficile disease: what really works?
    McFarland LV
    J Med Microbiol; 2005 Feb; 54(Pt 2):101-111. PubMed ID: 15673502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clostridium difficile-associated disease with lethal outcome in a 77-year-old woman. A case report.
    Pekova L; Shomov G; Mladenova I; Pellicano R
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):383-6. PubMed ID: 18043555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C-reactive protein is a useful predictor of metronidazole treatment failure in mild-to-moderate Clostridium difficile infection.
    Farne HA; Martin NK; Main J; Orchard T; Tyrrell-Price J
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):33-6. PubMed ID: 23026925
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Feces culture successful therapy in Clostridium difficile diarrhea].
    Jorup-Rönström C; Håkanson A; Persson AK; Midtvedt T; Norin E
    Lakartidningen; 2006 Nov 15-21; 103(46):3603-5. PubMed ID: 17153868
    [No Abstract]   [Full Text] [Related]  

  • 59. [Diarrhea due to a toxin of Clostridium difficile in hemato-oncological patients].
    Heering NJ
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1764-5. PubMed ID: 11572182
    [No Abstract]   [Full Text] [Related]  

  • 60. [Left-sided ulcerative colitis reactivated and aggravated during clostridium difficile infection].
    Na DK; Kim JB; Shin YC; Shin SL; Kim HJ; Baek IH; Park SH; Lee MS
    Korean J Gastroenterol; 2011 Jun; 57(6):374-8. PubMed ID: 21694491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.